ArticleTherapeutic advances in neurological disorders2025
Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorder.
Amelie Kirschbaum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.